spacer
spacer
spacer
spacer
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)—an individual participant data meta-analysis
Schoof LG, Rød BE, El Mahdaoui S, Michelsen JS, Høgestøl EA, Myhr KM, Rise HH, Su Z, Eriksson F, Friede T, Lundell H, Sellebjerg F, Sidaros K, Siebner HR, Wiggermann V, Jasperse B, Lissenberg-Witte B, Van Oosten BW, Schoonheim MM, Edan G, Gaubert M, Le Page E, Kerbrat A, Michel L, Strijbis EM, Torkildsen Ø and Christensen JR2026
cccc